Bioventus Inc.

From Bioventus's results release of 2026年11月2日; its quarterly report has since been filed.

• Revenue

  Actual

  $142.4M

  +2.7% y/y ↑
  -7.0% q/q ↓

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  $0.08

  +60% y/y ↑
  -83% q/q ↓

  Guided

  —

  No guide given

• Operating income, GAAP

  Actual

  $9.7M

  -14% y/y ↓
  -49% q/q ↓

  Guided

  —

  No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.